Case-control study of debrisoquine 4-hydroxylase, N-acetyltransferase 2, and apolipoprotein E gene polymorphisms in Parkinson's disease
Identifieur interne : 007633 ( Main/Merge ); précédent : 007632; suivant : 007634Case-control study of debrisoquine 4-hydroxylase, N-acetyltransferase 2, and apolipoprotein E gene polymorphisms in Parkinson's disease
Auteurs : D. M. Maraganore [États-Unis] ; M. J. Farrer [États-Unis] ; J. A. Hardy [États-Unis] ; S. K. Mcdonnell [États-Unis] ; D. J. Schaid [États-Unis] ; W. A. Rocca [États-Unis]Source :
- Movement disorders [ 0885-3185 ] ; 2000.
Descripteurs français
- Pascal (Inist)
- Wicri :
English descriptors
- KwdEn :
Abstract
We investigated the association of Parkinson's disease (PD) with two genes encoding liver-detoxifying enzymes, debrisoquine 4-hydroxylase (CYP2D6) and N-acetyltransferase 2 (NAT2), and with one gene related to Alzheimer's disease, apolipoprotein E (APOE). In a sample of 139 unrelated PD cases and 113 control subjects, the NAT2 M3 allele was associated with PD (odds ratio = 7.9; 95% confidence interval = 1.7-36.3). Case-control analyses for CYP2D6, APOE, and NAT2 M1 or M2 did not show a significant association. However, the age at onset of PD was significantly earlier in cases with the APOE ∈2/∈3 genotype than in cases with the ∈3/∈3 genotype.
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 002B87
- to stream PascalFrancis, to step Curation: 000134
- to stream PascalFrancis, to step Checkpoint: 002C41
Links to Exploration step
Pascal:00-0394759Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Case-control study of debrisoquine 4-hydroxylase, N-acetyltransferase 2, and apolipoprotein E gene polymorphisms in Parkinson's disease</title>
<author><name sortKey="Maraganore, D M" sort="Maraganore, D M" uniqKey="Maraganore D" first="D. M." last="Maraganore">D. M. Maraganore</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, Mayo Clinic and Mayo Foundation</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Farrer, M J" sort="Farrer, M J" uniqKey="Farrer M" first="M. J." last="Farrer">M. J. Farrer</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Molecular Genetics Laboratory, Mayo Clinic and Mayo Foundation</s1>
<s2>Jacksonville, Florida</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hardy, J A" sort="Hardy, J A" uniqKey="Hardy J" first="J. A." last="Hardy">J. A. Hardy</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Molecular Genetics Laboratory, Mayo Clinic and Mayo Foundation</s1>
<s2>Jacksonville, Florida</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mcdonnell, S K" sort="Mcdonnell, S K" uniqKey="Mcdonnell S" first="S. K." last="Mcdonnell">S. K. Mcdonnell</name>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Schaid, D J" sort="Schaid, D J" uniqKey="Schaid D" first="D. J." last="Schaid">D. J. Schaid</name>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rocca, W A" sort="Rocca, W A" uniqKey="Rocca W" first="W. A." last="Rocca">W. A. Rocca</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, Mayo Clinic and Mayo Foundation</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">00-0394759</idno>
<date when="2000">2000</date>
<idno type="stanalyst">PASCAL 00-0394759 INIST</idno>
<idno type="RBID">Pascal:00-0394759</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002B87</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000134</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002C41</idno>
<idno type="wicri:doubleKey">0885-3185:2000:Maraganore D:case:control:study</idno>
<idno type="wicri:Area/Main/Merge">007633</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Case-control study of debrisoquine 4-hydroxylase, N-acetyltransferase 2, and apolipoprotein E gene polymorphisms in Parkinson's disease</title>
<author><name sortKey="Maraganore, D M" sort="Maraganore, D M" uniqKey="Maraganore D" first="D. M." last="Maraganore">D. M. Maraganore</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, Mayo Clinic and Mayo Foundation</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Farrer, M J" sort="Farrer, M J" uniqKey="Farrer M" first="M. J." last="Farrer">M. J. Farrer</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Molecular Genetics Laboratory, Mayo Clinic and Mayo Foundation</s1>
<s2>Jacksonville, Florida</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hardy, J A" sort="Hardy, J A" uniqKey="Hardy J" first="J. A." last="Hardy">J. A. Hardy</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Molecular Genetics Laboratory, Mayo Clinic and Mayo Foundation</s1>
<s2>Jacksonville, Florida</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mcdonnell, S K" sort="Mcdonnell, S K" uniqKey="Mcdonnell S" first="S. K." last="Mcdonnell">S. K. Mcdonnell</name>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Schaid, D J" sort="Schaid, D J" uniqKey="Schaid D" first="D. J." last="Schaid">D. J. Schaid</name>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rocca, W A" sort="Rocca, W A" uniqKey="Rocca W" first="W. A." last="Rocca">W. A. Rocca</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, Mayo Clinic and Mayo Foundation</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2000">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acyltransferases</term>
<term>Apolipoprotein E</term>
<term>Debrisoquine</term>
<term>Exploration</term>
<term>Genetics</term>
<term>Human</term>
<term>Hydroxylase</term>
<term>Parkinson disease</term>
<term>Polymorphism</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Débrisoquine</term>
<term>Hydroxylase</term>
<term>Acyltransferases</term>
<term>Apolipoprotéine E</term>
<term>Polymorphisme</term>
<term>Exploration</term>
<term>Homme</term>
<term>Génétique</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
<term>Génétique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We investigated the association of Parkinson's disease (PD) with two genes encoding liver-detoxifying enzymes, debrisoquine 4-hydroxylase (CYP2D6) and N-acetyltransferase 2 (NAT2), and with one gene related to Alzheimer's disease, apolipoprotein E (APOE). In a sample of 139 unrelated PD cases and 113 control subjects, the NAT2 M3 allele was associated with PD (odds ratio = 7.9; 95% confidence interval = 1.7-36.3). Case-control analyses for CYP2D6, APOE, and NAT2 M1 or M2 did not show a significant association. However, the age at onset of PD was significantly earlier in cases with the APOE ∈2/∈3 genotype than in cases with the ∈3/∈3 genotype.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Floride</li>
<li>Minnesota</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Minnesota"><name sortKey="Maraganore, D M" sort="Maraganore, D M" uniqKey="Maraganore D" first="D. M." last="Maraganore">D. M. Maraganore</name>
</region>
<name sortKey="Farrer, M J" sort="Farrer, M J" uniqKey="Farrer M" first="M. J." last="Farrer">M. J. Farrer</name>
<name sortKey="Hardy, J A" sort="Hardy, J A" uniqKey="Hardy J" first="J. A." last="Hardy">J. A. Hardy</name>
<name sortKey="Mcdonnell, S K" sort="Mcdonnell, S K" uniqKey="Mcdonnell S" first="S. K." last="Mcdonnell">S. K. Mcdonnell</name>
<name sortKey="Rocca, W A" sort="Rocca, W A" uniqKey="Rocca W" first="W. A." last="Rocca">W. A. Rocca</name>
<name sortKey="Rocca, W A" sort="Rocca, W A" uniqKey="Rocca W" first="W. A." last="Rocca">W. A. Rocca</name>
<name sortKey="Schaid, D J" sort="Schaid, D J" uniqKey="Schaid D" first="D. J." last="Schaid">D. J. Schaid</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 007633 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 007633 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Merge |type= RBID |clé= Pascal:00-0394759 |texte= Case-control study of debrisoquine 4-hydroxylase, N-acetyltransferase 2, and apolipoprotein E gene polymorphisms in Parkinson's disease }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |